Clinasia
Services >> Phase IV >> Product Safety and Pharmacovigilance
     
  Product Safety and Pharmacovigilance  
     
 

ClinAsia Labs designs a customized safety plan through which ClinAsia Labs provides complete safety coverage round the clock. ClinAsia Labs ensures safety by closely maintaining clinical safety databases, effective monitoring through improved coordination of data monitoring committees and also using advanced alerting system which is automated with in a signal alarming system.

ClinAsia Labs product safety group is totally dedicated solely to collecting, interpreting and reporting safety events for the clients after their products win the approval for marketing. ClinAsia Labs team has extensive experience in the collection of safety information for around 100 products, covering a broad range of spectrum of therapeutic areas which ClinAsia Labs specializes in.

 
     
     
  Early Post-Approval Planning  
  Product Safety and Pharmacovigilance  
  Late Stage research services  
  Registries and Observational Studies  
     
 
 
ClinAsia Labs successfully provided services to a fortune 500 pharma company in the area of clinical data management.

-----------------------------------------------
ClinAsia Labs has provided end to end clinical research services in the field of Neurology to a global pharma company.

-----------------------------------------------
ClinAsia Labs has recently completed a study pathology with its expertise in the areas of EDC and Regulatory affairs for a global pharma company.

-----------------------------------------------
ClinAsia Labs successfully provided services to a fortune 500 pharma company in the area of clinical data management.

-----------------------------------------------
ClinAsia Labs has provided end to end clinical research services in the field of Neurology to a global pharma company.

-----------------------------------------------
ClinAsia Labs has recently completed a study pathology with its expertise in the areas of EDC and Regulatory affairs for a global pharma company.

-----------------------------------------------
 
 
 
   
   
   
   
 
     
 Copyright © 2008-2009. All Rights Reserved.  Sitemap | Legal Disclaimer